Exhibits
10-K
from 10-K
150 pages
10-K
03/11/20
EX-4.8
from 10-K
2 pages
Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
03/11/20
EX-10.66
from 10-K
1 page
Fifth Amendment to Office Lease
03/11/20
EX-10.67
from 10-K
9 pages
Severance Plan
03/11/20
EX-10.68
from 10-K
7 pages
Pdl Biopharma, Inc. Restricted Stock Agreement
03/11/20
EX-10.69
from 10-K
~1
page
Pdl Biopharma, Inc. Restricted Stock Agreement Amendment Acknowledgment
03/11/20
EX-10.70
from 10-K
11 pages
Pdl Biopharma, Inc. Stock Option Agreement
03/11/20
EX-10.71
from 10-K
1 page
Pdl Biopharma, Inc. Stock Option Agreement Amendment Acknowledgment
03/11/20
EX-10.72
from 10-K
2 pages
Pdl Biopharma, Inc. Stock Option Grant Notice Supplement
03/11/20
EX-10.73
from 10-K
11 pages
Pdl Biopharma, Inc. Nonstatutory Inducement Stock Option Agreement
03/11/20
EX-10.74
from 10-K
2 pages
Pdl Biopharma, Inc. Nonstatutory Inducement Stock Option Grant Notice Supplement
03/11/20
EX-10.75
from 10-K
8 pages
Pdl Biopharma, Inc. Inducement Restricted Stock Agreement
03/11/20
EX-10.76
from 10-K
5 pages
Pdl Biopharma, Inc. Wind Down Retention Plan
03/11/20
EX-21.1
from 10-K
1 page
Subsidiaries of the Registrant
03/11/20
EX-23.1
from 10-K
1 page
Consent of Independent Registered Public Accounting Firm
03/11/20
EX-31.1
from 10-K
1 page
Management certification of annual or quarterly disclosure
03/11/20
EX-31.2
from 10-K
1 page
Management certification of annual or quarterly disclosure
03/11/20
EX-32.1
from 10-K
~1
page
Management certification of financial report
03/11/20
